The relationship between dose and bioavailability of propranolol was determined in 12 healthy male subjects. The doses employed were 10, 40, 80 or 160mg of propanolol HCI given three times daily for 4 days. Daily minimum plasma levels showed that there was no accumulation of the drug. In all subject
The relationship between buspirone bioavailability and dose in healthy subjects
β Scribed by Dr. R. E. Gammans; R. F. Mayol; A. V. MacKenthun; L. F. Sokya
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 319 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
β¦ Synopsis
Dose dependency of the pharmacokinetics of buspirone, a new anxiolytic agent, was tested in 24 healthy volunteers. Each subject received 10, 20, and 40 mg doses according to a randomized, three-way crossover design with a 7-day interval between treatments. Buspirone AUC values at 10, 20, and 40 mg doses were in the ratio of 1:1.7:3.5 while C,,, values had a ratio of 1:1.9:3-7. The dose normalized (10 mg basis) AUC and C,,, values, T,,, values, and half-lives were not significantly different (p > 0.05 among the doses. Buspirone half-life did not change as a function of dose (mg doses in the therapeutic range.
π SIMILAR VOLUMES
## Abstract ## Objective Although obesity is widely accepted as a risk factor for knee osteoarthritis, it is not clear whether individual components of body composition, such as the mass and distribution of muscle and fat, are associated with development of the disease. This study examined the eff
The purpose of this study was to correlate subjective sleep characteristics based on questionnaire response, and objective sleep EEG features based on polysomnography, in 52 patients with major depressive disorders (MDD) and 49 healthy controls. With the exception of the number of awakenings, subjec
The present study examined the relationships between subjective reports of sleep and mental functioning. This was done both for healthy subjects and chronic fatigue syndrome patients, a group who frequently report sleep disorders. Sleep abnormalities were found to be related to personality and to st
Indinavir, a HIV-1 protease inhibitor, showed large inter-individual pharmacokinetic variability. It has been proposed as a substrate of P-glycoprotein (P-gp), an efflux transporter, that may contribute to limit indinavir bioavailability. A liquid formulation of indinavir was developed from indinavi